Clinical Research Directory
Browse clinical research sites, groups, and studies.
Treatment With Aspirin After Preeclampsia: TAP Trial
Sponsor: Malamo Countouris
Summary
The objective of this research project is to conduct a single-site pilot trial to assess the feasibility and effect of low-dose aspirin to augment vascular recovery in the immediate postpartum period after preeclampsia through two specific aims: 1) to pilot test the feasibility of conducting a randomized controlled trial of postpartum low dose aspirin vs. placebo, and 2) to assess the effect of postpartum aspirin on endothelial function and blood pressure. Our central hypothesis is that postpartum administration of low-dose aspirin following preeclampsia will be feasible, improve endothelial function, and lower BP at 6 months postpartum. Subjects will undergo 3 study visits involving BP measurements, blood draws, questionnaires, and/or microiontophoresis. Up to 60 adult subjects will be enrolled at Magee-Women's Hospital.
Key Details
Gender
FEMALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-05-29
Completion Date
2027-06-01
Last Updated
2026-02-05
Healthy Volunteers
No
Conditions
Interventions
Low-dose aspirin
The intervention group will receive low-dose \[81 mg\] aspirin pill daily for 6 months.
Placebo
The control group will receive similar appearing placebo daily for 6 months.
Locations (1)
University of Pittsburgh Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States